Advertisement
Screener

ROCKWELL MEDICAL, INC. (RMTI) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

ROCKWELL MEDICAL, INC. Operating Cash Flow

ROCKWELL MEDICAL, INC. (RMTI) reported Operating Cash Flow of $1.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13

  • ROCKWELL MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $2.08M, a 12.80% increase year-over-year.
  • ROCKWELL MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$167.00K.
  • ROCKWELL MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $2.29M, a 164.86% increase year-over-year.
  • ROCKWELL MEDICAL, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.31M, a 130.57% decline year-over-year.
  • ROCKWELL MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$659.00K, a 115.68% decline from fiscal 2024.
  • ROCKWELL MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2024 was $4.20M.
  • ROCKWELL MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$9.41M.
  • ROCKWELL MEDICAL, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$16.93M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30$2.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$1.91M
10-Q · filed 2026-08-13
$4.20M
derived: sum of 3 quarters · filed 2026-08-13
$2.90M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$167.00K
10-Q · filed 2026-05-07
$2.12M
derived: sum of 2 quarters · filed 2026-05-07
$817.00K
derived: sum of 3 quarters · filed 2026-05-07
$2.66M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$984.00K
derived: sum of 2 quarters · filed 2026-03-26
$2.83M
derived: sum of 3 quarters · filed 2026-08-13
-$659.00K
10-K · filed 2026-03-26
2025-09-30-$1.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$537.00K
derived: sum of 2 quarters · filed 2026-08-13
-$2.95M
10-Q · filed 2025-11-12
-$2.08M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$1.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$1.64M
10-Q · filed 2026-08-13
-$778.00K
derived: sum of 3 quarters · filed 2026-08-13
$3.50M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31-$3.49M
10-Q · filed 2026-05-07
-$2.62M
derived: sum of 2 quarters · filed 2026-05-07
$1.65M
derived: sum of 3 quarters · filed 2026-05-07
$3.10M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$865.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$5.14M
derived: sum of 2 quarters · filed 2026-03-26
$6.58M
derived: sum of 3 quarters · filed 2026-03-26
$4.20M
10-K · filed 2026-03-26
2024-09-30$4.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$5.72M
derived: sum of 2 quarters · filed 2025-11-12
$3.34M
10-Q · filed 2025-11-12
$3.29M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$1.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$938.00K
10-Q · filed 2025-08-14
-$981.00K
derived: sum of 3 quarters · filed 2025-08-14
-$4.73M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$2.38M
10-Q · filed 2025-05-12
-$2.42M
derived: sum of 2 quarters · filed 2025-05-12
-$6.18M
derived: sum of 3 quarters · filed 2025-05-12
-$7.92M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31-$43.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
-$3.80M
derived: sum of 2 quarters · filed 2025-03-20
-$5.54M
derived: sum of 3 quarters · filed 2025-03-20
-$9.41M
10-K · filed 2025-03-20
2023-09-30-$3.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$5.49M
derived: sum of 2 quarters · filed 2024-11-12
-$9.37M
10-Q · filed 2024-11-12
-$9.48M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$1.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$5.62M
10-Q · filed 2024-08-08
-$5.73M
derived: sum of 3 quarters · filed 2024-08-08
-$6.83M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$3.88M
10-Q · filed 2024-05-14
-$3.99M
derived: sum of 2 quarters · filed 2024-05-14
-$5.09M
derived: sum of 3 quarters · filed 2024-05-14
-$10.99M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$112.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21
-$1.21M
derived: sum of 2 quarters · filed 2024-03-21
-$7.12M
derived: sum of 3 quarters · filed 2024-03-21
-$16.93M
10-K · filed 2024-03-21
-$17.41M
10-K · filed 2023-03-30
2022-09-30-$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$7.01M
derived: sum of 2 quarters · filed 2023-11-14
-$16.82M
10-Q · filed 2023-11-14
-$16.82M
10-Q · filed 2022-11-14
-$25.84M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$5.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$15.71M
10-Q · filed 2023-08-14
-$15.72M
10-Q · filed 2022-08-15
-$24.74M
derived: sum of 3 quarters · filed 2023-08-14
-$31.82M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$9.81M
10-Q · filed 2023-05-15
-$9.81M
10-Q · filed 2022-05-16
-$18.84M
derived: sum of 2 quarters · filed 2023-05-15
-$25.91M
derived: sum of 3 quarters · filed 2023-05-15
-$30.85M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$9.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
-$16.10M
derived: sum of 2 quarters · filed 2023-03-30
-$21.04M
derived: sum of 3 quarters · filed 2023-03-30
-$33.53M
10-K · filed 2023-03-30
2021-09-30-$7.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$12.01M
derived: sum of 2 quarters · filed 2022-11-14
-$24.51M
10-Q · filed 2022-11-14
-$33.08M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$4.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15
-$17.43M
10-Q · filed 2022-08-15
-$26.00M
derived: sum of 3 quarters · filed 2022-08-15
-$30.92M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$12.49M
10-Q · filed 2022-05-16
-$21.06M
derived: sum of 2 quarters · filed 2022-05-16
-$25.98M
derived: sum of 3 quarters · filed 2022-05-16
-$35.60M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31-$8.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08
-$13.49M
derived: sum of 2 quarters · filed 2022-04-08
-$23.10M
derived: sum of 3 quarters · filed 2022-04-08
-$29.64M
10-K · filed 2022-04-08
2020-09-30-$4.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
-$14.53M
derived: sum of 2 quarters · filed 2021-11-15
-$21.07M
10-Q · filed 2021-11-15
-$26.37M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$9.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
-$16.15M
10-Q · filed 2021-08-16
-$16.15M
10-Q · filed 2020-08-10
-$21.45M
derived: sum of 3 quarters · filed 2021-08-16
-$27.63M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$6.54M
10-Q · filed 2021-05-17
-$6.54M
10-Q · filed 2020-05-11
-$11.84M
derived: sum of 2 quarters · filed 2021-05-17
-$18.01M
derived: sum of 3 quarters · filed 2021-05-17
-$28.37M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$5.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$11.48M
derived: sum of 2 quarters · filed 2021-03-31
-$21.83M
derived: sum of 3 quarters · filed 2021-03-31
-$27.25M
10-K · filed 2021-03-31
-$27.25M
10-K · filed 2020-03-17
2019-09-30-$6.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$16.53M
derived: sum of 2 quarters · filed 2020-11-09
-$21.95M
10-Q · filed 2020-11-09
-$21.95M
10-Q · filed 2019-11-12
-$27.74M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30-$10.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
-$15.78M
10-Q · filed 2020-08-10
-$21.56M
derived: sum of 3 quarters · filed 2020-08-10
-$26.34M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31-$5.42M
10-Q · filed 2020-05-11
-$11.21M
derived: sum of 2 quarters · filed 2020-05-11
-$15.99M
derived: sum of 3 quarters · filed 2020-05-11
-$21.24M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31-$5.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17
-$10.56M
derived: sum of 2 quarters · filed 2020-03-17
-$15.81M
derived: sum of 3 quarters · filed 2020-03-17
-$20.42M
10-K · filed 2020-03-17
2018-09-30-$4.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
-$10.03M
derived: sum of 2 quarters · filed 2019-11-12
-$14.64M
10-Q · filed 2019-11-12
-$14.62M
10-Q · filed 2018-11-09
-$19.45M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$5.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$9.86M
10-Q · filed 2019-08-09
-$9.85M
10-Q · filed 2018-08-14
-$14.67M
derived: sum of 3 quarters · filed 2019-08-09
-$18.85M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31-$4.61M
10-Q · filed 2019-05-10
-$4.60M
10-Q · filed 2018-05-10
-$9.42M
derived: sum of 2 quarters · filed 2019-05-10
-$13.60M
derived: sum of 3 quarters · filed 2019-05-10
-$20.64M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31-$4.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
-$9.00M
derived: sum of 2 quarters · filed 2019-03-18
-$16.04M
derived: sum of 3 quarters · filed 2019-03-18
-$21.11M
10-K · filed 2019-03-18
-$21.11M
10-K · filed 2018-03-15
2017-09-30-$4.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
-$11.23M
derived: sum of 2 quarters · filed 2018-11-09
-$16.30M
10-Q · filed 2018-11-09
-$15.76M
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30-$7.04M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-14
-$12.12M
10-Q · filed 2018-08-14
-$12.25M
10-Q · filed 2017-08-09
-$11.58M
derived: sum of 3 quarters · filed 2018-08-14
-$18.28M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31-$5.08M
10-Q/A · filed 2018-08-14
-$5.15M
10-Q · filed 2017-05-09
-$4.54M
derived: sum of 2 quarters · filed 2018-08-14
-$11.23M
derived: sum of 3 quarters · filed 2018-08-14
-$16.46M
derived: sum of 4 quarters · filed 2018-08-14
2016-12-31$537.78K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-$6.16M
derived: sum of 2 quarters · filed 2018-03-15
-$11.39M
derived: sum of 3 quarters · filed 2018-03-15
-$12.45M
10-K · filed 2018-03-15
2016-09-30-$6.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
-$11.92M
derived: sum of 2 quarters · filed 2017-11-08
-$12.99M
10-Q · filed 2017-11-08
-$12.78M
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30-$5.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
-$6.29M
10-Q · filed 2017-08-09
-$6.08M
derived: sum of 3 quarters · filed 2018-03-15
-$9.92M
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31-$1.07M
10-Q · filed 2017-05-09
-$853.91K
derived: sum of 2 quarters · filed 2018-03-15
-$4.69M
derived: sum of 3 quarters · filed 2018-03-15
-$11.08M
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31$211.59K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-$3.63M
derived: sum of 2 quarters · filed 2018-03-15
-$10.01M
derived: sum of 3 quarters · filed 2018-03-15
-$13.33M
10-K · filed 2018-03-15
-$16.24M
10-K · filed 2016-02-29
2015-09-30-$3.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
-$10.23M
derived: sum of 2 quarters · filed 2016-11-07
-$13.54M
10-Q · filed 2016-11-07
$4.02M
derived: sum of 4 quarters · filed 2017-03-15
2015-06-30-$6.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
-$9.70M
10-Q · filed 2016-08-09
$7.85M
derived: sum of 3 quarters · filed 2017-03-15
$8.17M
derived: sum of 4 quarters · filed 2017-03-15
2015-03-31-$3.31M
10-Q · filed 2016-05-10
$14.24M
derived: sum of 2 quarters · filed 2017-03-15
$14.56M
derived: sum of 3 quarters · filed 2017-03-15
$11.31M
derived: sum of 4 quarters · filed 2017-03-15
2014-12-31$17.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15
$17.87M
derived: sum of 2 quarters · filed 2017-03-15
$14.62M
derived: sum of 3 quarters · filed 2017-03-15
$4.26M
10-K · filed 2017-03-15
2014-09-30$313.95K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
-$2.93M
derived: sum of 2 quarters · filed 2015-11-09
-$13.30M
10-Q · filed 2015-11-09
-$21.44M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$3.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04
-$13.61M
10-Q · filed 2015-08-04
-$21.75M
derived: sum of 3 quarters · filed 2016-02-29
-$31.44M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$10.37M
10-Q · filed 2015-05-07
-$18.51M
derived: sum of 2 quarters · filed 2016-02-29
-$28.20M
derived: sum of 3 quarters · filed 2016-02-29
-$49.72M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$8.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$17.83M
derived: sum of 2 quarters · filed 2016-02-29
-$39.36M
derived: sum of 3 quarters · filed 2016-02-29
-$50.66M
10-K · filed 2016-02-29
2013-09-30-$9.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$31.21M
derived: sum of 2 quarters · filed 2014-11-10
-$42.52M
10-Q · filed 2014-11-10
-$49.69M
derived: sum of 4 quarters · filed 2015-03-03
2013-06-30-$21.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
-$32.83M
10-Q · filed 2014-07-31
-$40.00M
derived: sum of 3 quarters · filed 2015-03-03
-$48.80M
derived: sum of 4 quarters · filed 2015-03-03
2013-03-31-$11.31M
10-Q · filed 2014-05-12
-$18.48M
derived: sum of 2 quarters · filed 2015-03-03
-$27.27M
derived: sum of 3 quarters · filed 2015-03-03
-$33.75M
derived: sum of 4 quarters · filed 2015-03-03
2012-12-31-$7.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03
-$15.96M
derived: sum of 2 quarters · filed 2015-03-03
-$22.44M
derived: sum of 3 quarters · filed 2015-03-03
-$30.75M
10-K · filed 2015-03-03
2012-09-30-$8.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05
-$15.27M
derived: sum of 2 quarters · filed 2013-11-05
-$23.58M
10-Q · filed 2013-11-05
-$27.11M
derived: sum of 4 quarters · filed 2014-03-07
2012-06-30-$6.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01
-$14.79M
10-Q · filed 2013-08-01
-$18.32M
derived: sum of 3 quarters · filed 2014-03-07
-$20.61M
derived: sum of 4 quarters · filed 2014-03-07
2012-03-31-$8.30M
10-Q · filed 2013-05-08
-$11.84M
derived: sum of 2 quarters · filed 2014-03-07
-$14.13M
derived: sum of 3 quarters · filed 2014-03-07
-$14.52M
derived: sum of 4 quarters · filed 2014-03-07
2011-12-31-$3.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07
-$5.83M
derived: sum of 2 quarters · filed 2014-03-07
-$6.22M
derived: sum of 3 quarters · filed 2014-03-07
-$10.78M
10-K · filed 2014-03-07
2011-09-30-$2.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
-$2.69M
derived: sum of 2 quarters · filed 2012-11-09
-$7.25M
10-Q · filed 2012-11-09
-$6.42M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$396.32K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
-$4.96M
10-Q · filed 2012-08-07
-$4.13M
derived: sum of 3 quarters · filed 2013-03-18
-$4.55M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31-$4.56M
10-Q · filed 2012-05-07
-$3.73M
derived: sum of 2 quarters · filed 2013-03-18
-$4.15M
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$828.29K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$410.64K
derived: sum of 2 quarters · filed 2013-03-18
$2.10M
10-K · filed 2013-03-18
2010-09-30-$417.66K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
$1.27M
10-Q · filed 2011-11-04
2010-06-30$1.69M
10-Q · filed 2011-08-05
2009-12-31-$1.43M
10-K · filed 2012-03-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
BriaCell Therapeutics Corp. (BCTX)$0.037B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
PMGC Holdings Inc. (ELAB)United States$0.037B
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
NANOVIRICIDES, INC. (NNVC)United States$0.031B